Lenvatinib Significantly Improved Overall Survival in Older Patients with Locally Recurrent or Metastatic ... - Markets Insider

Lenvatinib Significantly Improved Overall Survival in Older Patients with Locally Recurrent or Metastatic ... Markets Insider The article, "Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial," reports the results of a prespecified subanalysis of younger patients (65 years of age or ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2xslo73
via IFTTT